These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1452805)

  • 1. Crossover trials comparing several treatments.
    Newcombe RG
    J Clin Periodontol; 1992 Nov; 19(10):785-7. PubMed ID: 1452805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The crossover experiment for clinical trials.
    Brown BW
    Biometrics; 1980 Mar; 36(1):69-79. PubMed ID: 7370374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carryover and the two-period crossover clinical trial.
    Willan AR; Pater JL
    Biometrics; 1986 Sep; 42(3):593-9. PubMed ID: 3567292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-period crossover designs for two treatments.
    Ebbutt AF
    Biometrics; 1984 Mar; 40(1):219-24. PubMed ID: 6733230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial interview and the therapeutic alliance.
    Martin BJ; Alcorn JD; Kapadia AS; Walsh DA; Stewart JS
    J Gt Houst Dent Soc; 1992 Dec; 64(5):8-10. PubMed ID: 1308143
    [No Abstract]   [Full Text] [Related]  

  • 6. The performance of the two-stage analysis of two-treatment, two-period crossover trials.
    Freeman PR
    Stat Med; 1989 Dec; 8(12):1421-32. PubMed ID: 2616932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Models and the use of signed rank tests.
    Maritz JS
    Stat Med; 1985; 4(2):145-53. PubMed ID: 4023474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On variance estimation in crossover designs.
    Kunert J
    Biometrics; 1987 Dec; 43(4):833-45. PubMed ID: 3427168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relative plaque removal effect of a prebrushing mouthrinse.
    Beiswanger BB; Mallatt ME; Mau MS; Katz BP
    J Am Dent Assoc; 1990 Feb; 120(2):190-2. PubMed ID: 2405034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential oils and interdental hygiene.
    Yengopal V
    SADJ; 2004 May; 59(4):155, 157, 170. PubMed ID: 15279091
    [No Abstract]   [Full Text] [Related]  

  • 11. A Bayesian analysis of the two-period crossover design for clinical trials.
    Grieve AP
    Biometrics; 1985 Dec; 41(4):979-90. PubMed ID: 3830262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of studies to evaluate plaque control agents.
    Fischman SL
    J Dent Res; 1979 Dec; 58(12):2389-95. PubMed ID: 292687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of treatment allocation procedures on nominal significance levels and bias.
    Kalish LA; Begg CB
    Control Clin Trials; 1987 Jun; 8(2):121-35. PubMed ID: 3608506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New detergent vehicles for dental plaque and their use in oral hygiene].
    Bertelli G
    Odontostomatol Implantoprotesi; 1975; (1):53-5. PubMed ID: 802396
    [No Abstract]   [Full Text] [Related]  

  • 15. A critique of recent research on the two-treatment crossover design.
    Fleiss JL
    Control Clin Trials; 1989 Sep; 10(3):237-43. PubMed ID: 2676339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal and/or Efficient Two treatment Crossover Designs for Five Carryover Models.
    Gondaliya J; Divecha J
    Int J Biostat; 2018 Nov; 14(2):. PubMed ID: 30471221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response adaptive designs with a variance-penalized criterion.
    Yi Y; Wang X
    Biom J; 2009 Oct; 51(5):763-73. PubMed ID: 19757432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the crossover design in the presence of residual effects.
    Lehmacher W
    Stat Med; 1991 Jun; 10(6):891-9. PubMed ID: 1876779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of mouthrinses in inhibiting the development of supragingival plaque over a 4-day period of no oral hygiene.
    Moran J; Addy M; Kohut B; Hovliaras CA; Newcombe RG
    J Periodontol; 1994 Oct; 65(10):904-7. PubMed ID: 7823270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimization, by its nature, precludes allocation concealment, and invites selection bias.
    Berger VW
    Contemp Clin Trials; 2010 Sep; 31(5):406. PubMed ID: 20457277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.